Synopsis of recent research by authors named "Shaomeng Wang"
- Shaomeng Wang's recent research has focused on innovative therapeutic strategies using PROTAC technology for targeted degradation of cancer-related proteins, demonstrating promising candidates such as ERD-1233 and MD-265, which show significant potential in treating ER+ breast cancer and leukemia, respectively.
- The author has also explored non-invasive methods to enhance mammalian calcium signaling through terahertz stimulation, aiming to mitigate limitations of current pharmacological approaches when managing cardiovascular and neurological disorders.
- Additionally, Wang's work includes examining the role of IL-10R inhibition in reprogramming tumor-associated macrophages to reverse drug resistance in multiple myeloma, highlighting the importance of immune modulation in cancer therapy.
